A novel human-specific soluble vascular endothelial growth factor receptor 1: Cell type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia

Circulation Research

Volumn 102, Issue 12, 2008, Pages 1566-1574

  Sela, Shay ^a   Itin, Ahuva ^a   Natanson Yaron, Shira ^b   Greenfield, Caryn ^b   Goldman Wohl, Debra ^b   Yagel, Simcha ^b   Keshet, Eli ^a,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

Preeclampsia; Soluble VEGF receptor; Splicing; Vascular smooth muscle cell; VEGF

Indexed keywords

MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 1 14; FLT1 PROTEIN, HUMAN; HYBRID PROTEIN; ISOPROTEIN; VASCULOTROPIN A;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL TYPE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIRST TRIMESTER PREGNANCY; HOMEOSTASIS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; RNA EDITING; SMOOTH MUSCLE FIBER; SWINE; SYNCYTIOTROPHOBLAST; UPREGULATION; VASCULAR SMOOTH MUSCLE; AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; CELL CULTURE; CHEMISTRY; CORNEA; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; PREGNANCY; PROTEIN PROCESSING; RNA SPLICING; SIGNAL TRANSDUCTION; TROPHOBLAST; VASCULARIZATION;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CORNEA; ENDOTHELIAL CELLS; FEMALE; HOMEOSTASIS; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SPECIFICITY; PHOSPHORYLATION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; RNA SPLICING; SIGNAL TRANSDUCTION; SUS SCROFA; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 48249090832     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.171504     Document Type: Article

References (18)

1. Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, During MJ. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet. 2004;36:827-835.
2. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling: in control of vascular function. Nat Rev Mol Cell Biol. 2006;7: 359-371.
3. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442.
4. Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development. 2000;127:3941-3946.
5. Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 2006;443: 993-997.
6. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and pro-teinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
7. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
8. Thomas CP, Andrews JI, Liu KZ. Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta. FASEB J. 2007; 21:3885-3895.
9. Motro B, Itin A, Sachs L, Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A. 1990;87:3092-3096.
10. Gluzman Z, Koren B, Preis M, Cohen T, Tsaba A, Cosset FL, Shofti R, Lewis BS, Virmani R, Flugelman MY. Endothelial cells are activated by angiopoeitin-1 gene transfer and produce coordinated sprouting in vitro and arteriogenesis in vivo. Biochem Biophys Res Commun. 2007;359:263-268.
11. Wang Z, Castresana MR, Newman WH. Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells. Biochem Biophys Res Commun. 2001;285:669-674.
12. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML. Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007;130:691-703.
13. Hughes TA. Regulation of gene expression by alternative untranslated regions. Trends Genet. 2006;22:119-122.
14. Levanon K, Eisenberg E, Rechavi G, Levanon EY. Adenosine-to-inosine RNA editing in Alu repeats in the human genome. EMBO Rep. 2005;6: 831-835.
15. Tenney B, Parker F. The placenta in toxemia of pregnancy. Am J Obstet Gynecol. 1940;39:1000-1005.
16. Heazell AE, Moll SJ, Jones CJ, Baker PN, Crocker IP. Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta. 2007;28(suppl A):S33-S40.
17. Crocker IP, Tanner OM, Myers JE, Bulmer JN, Walraven G, Baker PN. Syncytiotrophoblast degradation and the pathophysiology of the malariainfected placenta. Placenta. 2004;25:273-282.
18. Muehlenbachs A, Mutabingwa TK, Edmonds S, Fried M, Duffy PE. Hypertension and maternal-fetal conflict during placental malaria. PLoS Med. 2006;3:e446.